Synthesis and properties of mixed-metal porphyrin complexes for photodynamic therapy of cancer by 胡 晓君 & Hu Xiaojun
氏 名 
学 位 の 種 類 

















平成 29 年 3 月 22 日 
課程博士（学位規則第４条第１項） 
Synthesis and properties of mixed-metal porphyrin complexes 
for photodynamic therapy of cancer 
（癌の光線力学療法に用いるポルフィリン混合金属錯体の合成と
性質） 
主査 小谷  明 
副査 松永  司 
副査 北村 正典 
副査 後藤(中川) 享子 







In this study, to obtain potential photosensitizing anticancer agents with improved hydrophilicity 
and high tumor accumulation, a porphyrin framework, Pt(II)-based chemotherapeutic drug, and 
metal ions were combined (Ga-4cisPtTPyP, Ga-4transPtTPyP, In-4cisPtTPyP, In-4transPtTPyP 
Zn-4cisPtTPyP, Zn-4transPtTPyP, and 4Pt(dach)ClTPyP), and their photophysical and 
photochemical properties were investigated. All of these mixed-metal porphyrin complexes 
displayed reasonable water solubility, lack of aggregation, high singlet oxygen quantum yield due 
to Pt groups, and excellent photocytotoxicity. The impact of the presence of heavy metals, Zn(II), 
In(III), and Ga(III), on the photophysical and photochemical properties as well as PDT efficacy 
were studied. In addition, with accumulation in tumor tissue, 4Pt(dach)ClTPyP completely killed 
tumor cells, not simply displaying inhibition of tumor growth. The reasons for cell death may be 
attributed to high singlet oxygen quantum, internalization into nucleus, and an apoptosis pathway. 
Based on these experimental results, the peripheral combination of platinum(II) groups with a 
porphyrin framework, generating considerable Φ∆, makes a substantial contribution to the 
anticancer activity in photodynamic therapy.   
                                                
Introduction and Results 
Photodynamic therapy (PDT), combining three components: light, singlet oxygen (1O2), and a 
photosensitizer, is a curative treatment widely used for the treatment of various forms of cancer. 
Irradiated with light of wavelengths in the range 600–800 nm, the therapy determines singlet 
oxygen generation, which is an actively cytotoxic agent in PDT. Porphyrin-based sensitizers are 
thermodynamically and kinetically stable and show great retention or accumulation in tumors as 
the result of preferential binding to low-density lipoproteins. Functionalization with charged 
peripheral groups or insertion of metals into the core could make them water-soluble, markedly 
affecting their biodistribution and in vivo efficacy. For successful PDT treatment, an efficient 
photosensitizer must meet several conditions: (1) no cytotoxicity under dark, (2) reasonable 
cytotoxic 1O2 generation ability under light, (3) a high absorption coefficient in the long 
wavelength region, (4) reasonable water-solubility, and (5) selective accumulation to the tumor 
tissue. 
However, the notorious insolubility and aggregation of porphyrins in aqueous solutions negatively 
affect their cellular uptake and restrict in vivo activity and applications. Given these limitations, 
efforts have been devoted for developing water-soluble cationic porphyrins that can eliminate the 
formation of aggregates by increasing the electrostatic repulsion among charged functional groups. 
Meanwhile, some porphyrin and platinum conjugates have been synthesized with the purpose of 
improving both hydrophilicity and antitumor activity; these complexes exhibited excellent 
efficacy in sequential PDT treatments. Consequently, the system combining porphyrins and 
Pt-based complexes generated interesting synergistic treatment effects, achieving a tremendous 
enhancement in anticancer effects. 
In light of the potential advantages, we have focused on porphyrins and metalloporphyrins 
substituted with platinum-based anticancer drugs, aiming to enhance their hydrophilicity, thereby 
enabling in vivo evaluation. We also anticipated tumor-targeted effects. In this study, a porphyrin 
or metalloporphyrin framework and platinum(II)-based groups were combined to produce some 
new cationic porphyrins. Their photophysical and photochemical properties were investigated, and 
the photodynamic activities of these complexes in vitro and in vivo were evaluated. The 
complexes were found to manifest highly potent anticancer activity in vitro and in vivo. 
Chapter 1 Water-soluble metalloporphyrinates with excellent photo-induced anticancer activity 
resulting from high tumor accumulation 
To develop a water-soluble and tumor-targeted photosensitizer for PDT, a porphyrin framework 
containing the metal ion gallium(III) was combined with platinum(II)-based groups to produce 
two new pentacationic metalloporphyrinates (Ga-4cisPtTPyP and Ga-4transPtTPyP, Scheme 1). 
The mixed-metal porphyrinate, Ga-4cisPtPyP, is an efficient singlet oxygen generator because of 
heavy atom effect, more acidic pKa, and localization in cytosol. It also showed negative dark 
cytotoxicity caused by more hydrophilicity and slower and lower cellular uptake. In particular, 
Ga-4cisPtTPyP displayed a low IC50 value (Colon 26: 0.12 μM; Sarcoma 180: 0.08 μM, Table 1) 
under illumination and its phototoxic index up to 1,000. We proposed that the excellent 
photocytotoxicity, interaction with DNA, and apoptosis pathway could contribute to the anticancer 
activity of Ga-4cisPtPyP. With outstanding tumor accumulation (tumor/muscle ratio > 9), 
Ga-4cisPtTPyP almost completely inhibited tumor growth over two weeks in an in vivo PDT 
assay (Fig. 1). These results imply that Ga-4cisPtTPyP could be a promising anticancer agent for 
use in PDT. 
 Scheme 1. Synthesis of Ga-4cisPtTPyP, Ga-4transPtTPyP and 4cisPtTPyP. 
Table 1 IC50 values (μM) toward Colon 26 and Sarcoma 180. 
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a Cancer cells were incubated for 24 h with different complexes. 
 b PI: phototoxic index 
Fig. 1. (a) Relative weight after treatment of Ga-4cisPtTPyP on BALB/c mice; (b) Tumor growth 
curves of control group and Ga-4cisPtTPyP treated group. The tumor volumes were normalized to 
their initial sizes. The error bars represent the standard deviations of 5 mice per group. *, p < 0.05; 
**, p < 0.01. 
Chapter 2 Effect of metalation on water-soluble cationic metalloporphyrins in photodynamic 
therapy 
To further investigate the effect of metalation on water-soluble cationic 
metalloporphyrins in photodynamic therapy, M-4PtTPyP (M=Zn and In), namely 
Zn-4cisPtTPyP, Zn-4transPtTPyP, In-4cisPtTPyP, and In-4transPtTPyP, were 
synthesized and studied for the first time (Scheme 2). We demonstrated the impact of 
the presence of heavy metals, Zn, In, and Ga, on the photophysical and photochemical 
properties as well as PDT efficacy. The ranking of overall charges for these 
complexes, is listed as follows: 
In-4cisPtTPyP, In-4transPtTPyP, Ga-4cisPtTPyP, and Ga-4transPtTPyP (5+) > 
Zn-4cisPtTPyP and Zn-4transPtTPyP (4+) > InTPyP and GaTPyP (1+) > ZnTPyP (0) 
From the results, an increase in the overall charge results in a decrease in logP values  
Scheme 2. Synthesis of Zn-4cisPtTPyP, Zn-4transPtTPyP, In-4cisPtTPyP, and 
In-4transPtTPyP.  
Table 2 The logP (n-octanol/water) values and quantum yields of singlet oxygen. 
Compound   logP    Φ∆ 
Zn-4cisPtTPyP -1.63±0.16 1.52±0.41 
Zn-4transPtTPyP -1.59±0.11 0.80±0.27 
In-4cisPtTPyP -1.97±0.19 0.76±0.07 
In-4transPtTPyP -1.92±0.26 0.62±0.28 
Ga-4cisPtTPyP -2.06±0.21 0.76±0.08 
Ga-4transPtTPyP -1.91±0.20 0.63±0.09 
4cisPtTPyP -1.77±0.08 0.57±0.03 
ZnTPyP 1.19±0.07 0.35±0.07 
InTPyP 0.96±0.06 0.35±0.10 
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and an increase in water solubility. These properties were affected significantly by changing the central 
metal cation in the studied platinum-porphyrin complexes. Additionally, the increasing of atom size of 
central metal enhanced the efficiency of singlet oxygen generation (Table 2). The presence of the heavy 
metal in porphyrins can decrease the energy difference between the singlet state and the excited triplet state 
of photosensitizers and increase its triplet state lifetime, in a process known as the heavy-atom effect. 
Although Zn-Pt porphyrins can generate the largest singlet oxygen and show stable under irridiation, these 
two complexes do not have the potential to serve for PDT since their poor solubility and low phototoxic 
indexes in vitro PDT assay. However, In-Pt porphyrins showed good photophysical and photochemical 
properties and it can be good candidates as Type II photosensitizers in photodynamic therapy applications. 
Chapter 3 A platinum-porphyrin conjugate: an excellent cancer killer for photodynamic therapy 
A cationic porphyrin of structural dependence on Pt moiety was further studied to develop another potential 
photosensitizing agent with high antitumor effect. In this part, a porphyrin framework as a carrier to tumor 
tissue and a Pt (II)-based chemotherapeutic drug were combined and characterized (Scheme 3). The 
positive charge-rich regions of this complex prohibit formation of aggregates by electrostatic repulsion and 
facilitate metal-to-ligand charge transition to increase singlet oxygen quantum. The tetracationic 
porphyrin-platinum(II) conjugate (4Pt(dach)ClTPyP) displayed reasonable water solubility, lack of 
aggregation, high singlet oxygen quantum yield, and excellent photocytotoxicity. This complex triggered 
caspase-3 induced apoptosis under irradiation. With accumulation in tumor tissue, 4Pt(dach)ClTPyP 
completely killed tumor cells, not simply displaying inhibition of tumor growth (Fig. 2). The reasons for 
cell death may be attributed to high singlet                                                       
oxygen quantum, internalization into nucleus, and an apoptosis pathway. Based on these experimental 
results, 4Pt(dach)ClTPyP is a highly promising anticancer agent for PDT.  
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Scheme 3 Synthesis of 4Pt(dach)ClTPyP. 
          
 
Fig. 2. In vivo PDT evaluation of 4Pt(dach)ClTPyP in Conlon26 tumor-bearing mice. 
(a) Tumor growth curves of group 1 (4Pt(dach)ClTPyP, n = 4) and group 2 (Control, n 
= 4). The tumor volumes were normalized to their initial sizes. (b) Relative weight of 
group 1 and group 2. The error bars represent the standard deviations of 4 mice per 
group. *, p < 0.05; **, p < 0.01, ***, p < 0.001.  
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審査結果の要旨 
 
PDT(photodynamic therapy：光線力学療法)は光照射によって光感受性薬
剤から一重項酸素を発生させて標的を攻撃する手法で，近年肺がん治療
等に応用されているが，よりよい PDT薬剤が望まれている。本研究は，
テトラピリジルポルフィリン（TPyP）に複数金属を異なる部位へ導入し，
１）高い光活性，２）腫瘍集積性などの動態優位性，３）高い in vitro
および in vivo抗がん活性，を発現させることを目的とした。光照射に
よる一重項酸素発生能は，混合金属系 M-4Pt-TPyPが最も高く，次いで側
鎖白金錯体 4Pt-TPyPであった。一重項酸素発生能と低い IC50値（高い
活性）は比例しており，Pt部位の重要性が示された。混合金属系におい
ては高い腫瘍集積性，光非照射下の低毒性等，動態での優位性が認めら
れた。マウス動態からは標的臓器内での錯体の分解が示され，抗がん活
性への寄与が示唆された。担がんマウスを用いた PDT治療実験において
は非常に優れた治療効果を認め，よりよい PDT薬剤の開発に際してポル
フィリンの混合金属錯体化が有用な方法であることを明らかにした。こ
れらの知見は創薬の学術面で大きく貢献している。以上より，本論文は
博士（創薬科学）に値すると判断される。 
